Prevalence and Management of Cancer of the Rectal Stump After Total Colectomy and Rectal Sparing in Patients with Familial Polyposis: Results from a Registry-Based Study
Overview
Authors
Affiliations
Background: The balance between quality of life and colorectal cancer risk in familial adenomatous polyposis (FAP) patients is of primary importance. A cut-off of less than 30 polyps under 1 cm of diameter in the rectum has been used as an indication for performing ileo-rectal anastomosis (IRA) in terms of lower rectal cancer risk. This study aimed to assess clinical and surgical features of FAP patients who developed cancer of the rectal stump.
Methods: This retrospective study included all FAP patients who underwent total colectomy/IRA from 1977 to 2021 and developed subsequent rectal cancer. Patients' features were reported using descriptive statistics by considering the overall case series and within pre-specified classes of age (<20, 20-30, and >30 years) at first surgery.
Results: Among the 715 FAP patients, 47 (6.57%, 95% confidence interval: 4.87; 8.65) developed cancer in the rectal stump during follow-up. In total, 57.45% of the population were male and 38.30% were proband. The median interval between surgery and the occurrence of rectal cancer was 13 years. This interval was wider in the youngest group (-value: 0.012) than the oldest ones. Twelve patients (25.53%) received an endoscopic or minimally invasive resection. Amongst them, 61.70% were Dukes stage A cancers.
Conclusions: There is a definite risk of rectal cancer after total colectomy/IRA; however, the time interval from the index procedure to cancer developing is long. Minimally invasive and endoscopic treatments should be the procedures of choice in patients with early stage cancers.
Thirty-year compliance with a surveillance program for patients with familial adenomatous polyposis.
de Langavant B, Lefevre J, Metras J, Dardenne A, OConnell L, Collard M Fam Cancer. 2025; 24(1):19.
PMID: 39890667 DOI: 10.1007/s10689-025-00441-3.
Rausa E, Colletti G, Ciniselli C, Signoroni S, Duroni V, Cavalcoli F Tech Coloproctol. 2023; 27(12):1327-1334.
PMID: 37688717 DOI: 10.1007/s10151-023-02858-3.
Special Issue "Current Management of Early and Advanced Rectal Cancer".
Belli F Cancers (Basel). 2023; 15(14).
PMID: 37509237 PMC: 10377096. DOI: 10.3390/cancers15143574.
Colletti G, Ciniselli C, Rausa E, Signoroni S, Cocco I, Magarotto A Cancers (Basel). 2022; 14(13).
PMID: 35805013 PMC: 9265077. DOI: 10.3390/cancers14133241.
Serrano D, Feroce I, Bonanni B, Bertario L Cancers (Basel). 2022; 14(11).
PMID: 35681630 PMC: 9179353. DOI: 10.3390/cancers14112650.